Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Pharm ; 511(1): 312-321, 2016 Sep 10.
Article in English | MEDLINE | ID: mdl-27377012

ABSTRACT

The API triethylenetetramine dihydrochloride used as an alternative treatment of Wilson's disease is sensitive to water and it exhibits polymorphism. As this may become an issue for the drug formulation, the physical stability has been studied by differential scanning calorimetry, high-pressure thermal analysis, dynamic vapor sorption, and X-ray diffraction as a function of temperature. In addition, high-pressure liquid chromatography and mass spectrometry have been used to study the purity and chemical stability of the API. A pressure-temperature phase diagram of the pure compound has been constructed and it can be concluded that form II is monotropic in relation to form I, which is the only stable solid. The solubilities of the different solid forms have been determined with the help of a temperature - composition phase diagram. The API is very soluble, at 20° C about 10% of the saturated solution with respect to the dihydrate consists of API and the solubility of the pure form I is twice as high. Moreover, it has been shown that at 20°C, a relative humidity above 40% induces the formation of the dihydrate and at 70% a saturated solution appears. At higher temperatures, the formation of the dihydrate appears at lower relative humidity values. A clear link has been established between the API's chemical stability, its physical stability and the relative humidity in the air. Humidity levels above 40% are detrimental to the quality of the API.


Subject(s)
Trientine/chemistry , Trientine/metabolism , Calorimetry, Differential Scanning/methods , Drug Stability , Magnetic Resonance Spectroscopy/methods , Solubility
2.
J Pharm Biomed Anal ; 105: 74-83, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25543285

ABSTRACT

Ticagrelor is a direct-acting and reversible P2Y12-adenosine diphosphate (ADP) receptor blocker used as antiplatelet drug. Forced degradation under various stress conditions was carried out. The degradation products have been detected and identified by high-pressure liquid chromatography multistage mass spectrometry (LC-MS(n)) along with high-resolution mass spectrometry. C18 XTerra MS column combined with a linear gradient mobile phase composed of a mixture of 10 mM acetate ammonium/acetonitrile was shown suitable for drug and impurity determinations and validated as a stability indicating method. Structural elucidation of the degradation products relied on MS(n) studies and accurate mass measurements giving access to elemental compositions. Up to nine degradation products resulting from oxidation/auto-oxidation, S-dealkylation and N-dealkylation have been identified, covering a range of possible degradation pathways for derivatives with such functional groups. Kinetics was also studied in order to assess the molecule's shelf-life and to identify the most important degradation factors.


Subject(s)
Adenosine/analogs & derivatives , Chromatography, Reverse-Phase/methods , Mass Spectrometry/methods , Platelet Aggregation Inhibitors/analysis , Purinergic P2Y Receptor Antagonists/analysis , Adenosine/analysis , Adenosine/chemistry , Adenosine/radiation effects , Chromatography, Reverse-Phase/instrumentation , Drug Contamination , Drug Stability , Hot Temperature , Hydrolysis , Limit of Detection , Molecular Structure , Oxidation-Reduction , Photolysis , Platelet Aggregation Inhibitors/chemistry , Platelet Aggregation Inhibitors/radiation effects , Purinergic P2Y Receptor Antagonists/chemistry , Purinergic P2Y Receptor Antagonists/radiation effects , Reproducibility of Results , Ticagrelor
3.
J Pharm Biomed Anal ; 96: 58-67, 2014 Aug 05.
Article in English | MEDLINE | ID: mdl-24726889

ABSTRACT

Tienoxolol is a pharmacologically active molecule designed with the functional groups ketothiophene, alkyl benzoate and arylpropanolamine so as to combine a diuretic and a ß-adrenoreceptor antagonist into a single molecule. Its degradation products generated in several stress media have been determined by high-pressure liquid chromatography (HPLC) coupled to a hybrid mass spectrometer with a triple quadrupole-linear trap. A Polaris(®) column with a C18-A stationary phase and a linear gradient mobile phase composed of a mixture of trifluoroacetic acid 1% (v/v) and acetonitrile allowed for optimal separation. Structural elucidation of the degradation products has been based on MS/MS techniques, by comparing their fragmentation patterns to the precursor's data. Up to seven degradation products of the active ingredient, resulting from hydrolysis, oxidation, dehydration and transamidation have been identified, covering a range of possible degradation pathways for derivatives with such functional groups. Kinetics have been studied to assess the molecule's shelf life and to identify the most important degradation factor.


Subject(s)
Chromatography, High Pressure Liquid/methods , Propanolamines/analysis , Spectrometry, Mass, Electrospray Ionization/methods , Adrenergic beta-Antagonists/analysis , Adrenergic beta-Antagonists/chemistry , Drug Stability , Drug Storage , Propanolamines/chemistry , Tandem Mass Spectrometry/methods
SELECTION OF CITATIONS
SEARCH DETAIL